eMagin (NYSE:EMA – Get Free Report) had its price target lowered by equities research analysts at Barclays from $53.00 to $52.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s target price would suggest a potential downside of 1.87% from the stock’s current price.
A number of other analysts have also recently commented on EMA. Wall Street Zen raised shares of eMagin from a “strong sell” rating to a “sell” rating in a research note on Saturday, April 18th. Bank of America lowered shares of eMagin from a “buy” rating to a “neutral” rating in a report on Monday, January 12th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $56.33.
Check Out Our Latest Stock Report on EMA
eMagin Stock Up 0.7%
Institutional Investors Weigh In On eMagin
Several institutional investors have recently modified their holdings of EMA. Parallel Advisors LLC increased its holdings in eMagin by 130.9% in the first quarter. Parallel Advisors LLC now owns 508 shares of the company’s stock valued at $26,000 after buying an additional 288 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of eMagin by 1,375.0% during the fourth quarter. EverSource Wealth Advisors LLC now owns 708 shares of the company’s stock worth $35,000 after purchasing an additional 660 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of eMagin by 12.1% in the 1st quarter. Venturi Wealth Management LLC now owns 8,111 shares of the company’s stock valued at $421,000 after purchasing an additional 877 shares during the period. Versant Capital Management Inc acquired a new stake in shares of eMagin in the third quarter valued at approximately $284,000. Finally, Syon Capital LLC purchased a new position in shares of eMagin during the third quarter worth approximately $306,000.
eMagin Company Profile
eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode (OLED) miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL. The company also provides design reference kits, which include a micro display and associated electronics to help original equipment manufacturers (OEMs) to evaluate micro display products; near-eye virtual imaging modules that incorporate its OLED-on-silicon micro displays with its lenses and electronic interfaces for integration into OEM products; prism optics, a molded plastic prism lens that permits its AMOLED micro displays to provide realistic images that can be viewed for extended periods with reduced eye-fatigue; and driver boards.
Featured Stories
- Five stocks we like better than eMagin
- Catching Falling Knives: Is Time to Buy These Beaten-Down Stocks?
- The Stars Are Aligning For Apple: Get Ready for $300
- 3 Small-Cap Stocks to Buy as the Russell 2000 Extends Its Rally
- Tapestry Stock Drops After Strong Quarter and Raised Outlook
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
